https://www.selleckchem.com/pr....oducts/pd-1-pd-l1-in
of infection are consistent with those of other populations. There are large inequities in the lung cancer burden for the Indigenous Māori population of New Zealand. We model the potential lifetime health gains, equity impacts and cost-effectiveness of a national low-dose CT (LDCT) screening programme for lung cancer in smokers aged 55-74 years with a 30 pack-year history, and for formers smokers who have quit within the last 15 years. A Markov macrosimulation model estimated health benefits (health-adjusted life-years (H
Aimer
Commentaire
Partagez
